Somatic comorbidity of schizophrenia
De Beaurepaire, R.
La Revue du Praticien 63(3): 344-345
2013
ISSN/ISBN: 0035-2640 PMID: 23687759 Document Number: 666559
Document emailed within 1 workday
Related Documents
Maier, W.; Falkai, P. 1999: The epidemiology of comorbidity between depression, anxiety disorders and somatic diseases International Clinical Psychopharmacology 14(Suppl): S1-S6Damjanović, A.; Ivković, M.; Jasović-Gasić, M.; Paunović, V. 2006: Comorbidity of schizophrenia and cancer: clinical recommendations for treatment Psychiatria Danubina 18(1-2): 55-60
Roth, M.; McClelland, R.A. 1971: Sensory defects, physical deformity and somatic diseases in schizophrenia Vestnik Akademii Meditsinskikh Nauk SSSR 26(5): 77-79
Braun, I.M.; Liang, M.H.; Orav, E.John.; Ahern, D.K.; Barsky, A.J. 2008: A personality characteristic, somatic absorption, and the perception of somatic symptoms in rheumatoid arthritis patients Journal of Rheumatology 35(5): 782-789
Solov'ev, V.V.; Rogozin, I.V.; Kolchanov, N.A. 1989: Somatic hypermutagenesis in immunoglobulin genes. I. Connection of somatic mutations with repeats. a statistical weighting method Molekuliarnaia Biologiia 23(3): 783-794
Odoevskaia, I.M.; Kurnosova, O.P. 2007: Comparative immunochemical analysis of a complete somatic extract, somatic fractionated and excretory-secretory proteins and antigens of T. spiralis larvae Meditsinskaia Parazitologiia i Parazitarnye Bolezni 2007(2): 24-29
Pessacq, T.P. 1973: Structural studies on the synapsis of the toad, Bufo arenarum, Hensel. I. Special forms of dendro-dendritic, dendro-somatic and axo-somatic contacts Acta Anatomica 84(1): 31-42
Schooler, N.R.; Keith, S.J.; Severe, J.B.; Matthews, S. 1989: Acute treatment response and short term outcome in schizophrenia: first results of the NIMH treatment strategies in schizophrenia study. Treatment Strategies in Schizophrenia Collaborative Study Group Psychopharmacology Bulletin 25(3): 331-335
Zaytseva, Y.; Burova, V.; Garakh, Z.; Gurovich, I.Y. 2013: Attributional style in fist episode of schizophrenia and schizophrenia spectrum disorders with and without paranoid ideation Psychiatria Danubina 25(Suppl 2): S329-S331
Roxo, H. 1952: Pseudoneurotics; patients at the onset of schizophrenia; differential diagnosis of neurasthenia and schizophrenia; modern therapy Imprensa Medica 28(463): 25-30
Tsirkin, S.Iu. 1987: International study of schizophrenia based on a WHO program. Incidence of schizophrenia Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 87(8): 1203-1207
Kotlicka-Antczak, M.; Rabe-Jabłońska, J. 1997: Neurodevelopmental schizophrenia: the concept of developmental origins of certain forms of schizophrenia Psychiatria Polska 31(5): 527-538
Arraras, J.I.; Basterra, I.; Pereda, N.; Ibañez, B.; Iribarren, S.; Cabases, J.M. 2019: The Schizophrenia Quality of Life Scale Revision 4 (SQLS-R4) questionnaire. A validation study with Spanish schizophrenia spectrum outpatients Actas Espanolas de Psiquiatria 47(3): 97-109
Suzuki, S. 1982: The mental maturation and verbal alteration in a mild case of chronic non-paranoiac schizophrenia. a linguistic-phenomenological approach to the concept of schizophrenia simplex Seishin Shinkeigaku Zasshi 84(1): 1-19
Hargreaves, W.A.; Kane, J.M.; Ninan, P.T.; Severe, J.B.; Woerner, M. 1989: Demographic characteristics, treatment history, presenting psychopathology and early course in schizophrenia. Treatment Strategies in Schizophrenia Collaborative Study Group Psychopharmacology Bulletin 25(3): 340-343
Williams, J.; Spurlock, G.; McGuffin, P.; Mallet, J.; Nöthen, M.M.; Gill, M.; Aschauer, H.; Nylander, P.O.; Macciardi, F.; Owen, M.J. 1996: Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene. European Multicentre Association Study of Schizophrenia (EMASS) Group Lancet 347(9011): 1294-1296
Keefe, R.S.; Mohs, R.C.; Davidson, M.; Losonczy, M.F.; Silverman, J.M.; Lesser, J.C.; Horvath, T.B.; Davis, K.L. 1988: Kraepelinian schizophrenia: a subgroup of schizophrenia? Psychopharmacology Bulletin 24(1): 56-61
Glick, I.D.; Jacobs, M.; Lieberman, J.; Simpson, G.; Schooler, N.R. 1989: Prediction of short term outcome in schizophrenia: depressive symptoms, negative symptoms, and extrapyramidal signs. Treatment Strategies in Schizophrenia Collaborative Study Group Psychopharmacology Bulletin 25(3): 344-347
Dadić-Hero, E.; Ruzić, K.; Palijan, T.Z.ć; Graovac, M.; Siuc-Valković, D.; Knez, R.; Grahovac, T. 2013: Relations between the course of illness, family history of schizophrenia and family functioning in persons with schizophrenia Collegium Antropologicum 37(1): 47-55
Degreef, I. 2016: Comorbidity in Dupuytren disease Acta Orthopaedica Belgica 82(3): 643-648